1.42
price down icon2.07%   -0.03
 
loading

Hillevax Inc Borsa (HLVX) Ultime notizie

pulisher
Apr 03, 2025

HKVX INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm Today! - ACCESS Newswire

Apr 03, 2025
pulisher
Apr 01, 2025

HilleVax (NASDAQ:HLVX) Given Neutral Rating at HC Wainwright - Defense World

Apr 01, 2025
pulisher
Mar 31, 2025

Cautious Hold Rating on HilleVax Amid Norovirus Vaccine Development Setbacks - TipRanks

Mar 31, 2025
pulisher
Mar 30, 2025

HilleVax Reports 2024 Financial Results Amid Strategic Exploration - MSN

Mar 30, 2025
pulisher
Mar 28, 2025

HilleVax Inc. (HLVX) reports earnings - Quartz

Mar 28, 2025
pulisher
Mar 28, 2025

HilleVax, Inc. SEC 10-K Report - TradingView

Mar 28, 2025
pulisher
Mar 28, 2025

HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress - The Manila Times

Mar 28, 2025
pulisher
Mar 25, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate HilleVax, Inc. (HLVX) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Mar 25, 2025
pulisher
Mar 13, 2025

HilleVax (HLVX) to Release Quarterly Earnings on Wednesday - Defense World

Mar 13, 2025
pulisher
Mar 12, 2025

HILLEVAX Earnings Preview: Recent $HLVX Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 12, 2025
pulisher
Mar 10, 2025

HilleVax (NASDAQ:HLVX) & Omega Therapeutics (NASDAQ:OMGA) Critical Survey - Defense World

Mar 10, 2025
pulisher
Feb 27, 2025

HKVX STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Investors to Contact the Firm! - ACCESS Newswire

Feb 27, 2025
pulisher
Feb 17, 2025

Hillevax CFO Shane Maltbie sells $15,116 in stock By Investing.com - Investing.com Nigeria

Feb 17, 2025
pulisher
Feb 17, 2025

Stocks of HilleVax Inc (HLVX) are poised to climb above their peers - SETE News

Feb 17, 2025
pulisher
Feb 15, 2025

Hillevax CEO Robert Hershberg sells $48,661 in stock - MSN

Feb 15, 2025
pulisher
Feb 15, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by SG Americas Securities LLC - Defense World

Feb 15, 2025
pulisher
Feb 13, 2025

Hillevax CFO Shane Maltbie sells $15,116 in stock - MSN

Feb 13, 2025
pulisher
Feb 13, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Qiming U.S. Ventures Management LLC - MarketBeat

Feb 13, 2025
pulisher
Feb 12, 2025

Top Executives Cash In on HilleVax Stock Sales - TipRanks

Feb 12, 2025
pulisher
Feb 12, 2025

HilleVax Executives Sell Shares in February 2025 - TradingView

Feb 12, 2025
pulisher
Feb 12, 2025

Vitro Diagnostics (OTCMKTS:VODG) vs. HilleVax (NASDAQ:HLVX) Financial Review - Defense World

Feb 12, 2025
pulisher
Jan 27, 2025

HKVX SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into HilleVax, Inc. and Encourages Stockholders to Contact the Firm! - ACCESS Newswire

Jan 27, 2025
pulisher
Jan 25, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Purchased by Barclays PLC - Defense World

Jan 25, 2025
pulisher
Jan 14, 2025

Jane Street Group LLC Purchases 35,546 Shares of HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Jan 14, 2025
pulisher
Jan 10, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by Geode Capital Management LLC - Defense World

Jan 10, 2025
pulisher
Jan 10, 2025

Barclays PLC Raises Holdings in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Jan 10, 2025
pulisher
Jan 07, 2025

Critical Comparison: Zura Bio (NASDAQ:ZURA) versus HilleVax (NASDAQ:HLVX) - Defense World

Jan 07, 2025
pulisher
Jan 03, 2025

HilleVax, Inc. (NASDAQ:HLVX) Shares Sold by State Street Corp - Defense World

Jan 03, 2025
pulisher
Jan 02, 2025

Cancer Vaccine Breaking News - Vax-Before-Travel

Jan 02, 2025
pulisher
Jan 01, 2025

Short Interest in HilleVax, Inc. (NASDAQ:HLVX) Expands By 7.4% - MarketBeat

Jan 01, 2025
pulisher
Dec 20, 2024

Charles Schwab Investment Management Inc. Has $133,000 Stake in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Dec 20, 2024
pulisher
Dec 19, 2024

Critical Survey: Fate Therapeutics (NASDAQ:FATE) versus HilleVax (NASDAQ:HLVX) - Defense World

Dec 19, 2024
pulisher
Dec 15, 2024

Financial Contrast: Vericel (NASDAQ:VCEL) versus HilleVax (NASDAQ:HLVX) - Defense World

Dec 15, 2024
pulisher
Dec 10, 2024

HilleVax, Inc. Announces Management Changes - Marketscreener.com

Dec 10, 2024
pulisher
Dec 09, 2024

3 US Penny Stocks With Market Caps Under $100M - simplywall.st

Dec 09, 2024
pulisher
Dec 06, 2024

HilleVax initiates major workforce reduction, executives depart By Investing.com - Investing.com Australia

Dec 06, 2024
pulisher
Dec 05, 2024

HilleVax initiates major workforce reduction, executives depart - Investing.com

Dec 05, 2024
pulisher
Dec 05, 2024

HilleVax Shares Rise After Announcing Job Cuts, Executive Departures - MarketWatch

Dec 05, 2024
pulisher
Dec 05, 2024

HilleVax, Inc. Announces Workforce Reduction and Leadership Changes - TipRanks

Dec 05, 2024
pulisher
Dec 05, 2024

Head to Head Survey: HilleVax (NASDAQ:HLVX) versus NKGen Biotech (NYSE:NKGN) - Defense World

Dec 05, 2024
pulisher
Dec 02, 2024

JP Morgan Downgrades HilleVax (HLVX) - MSN

Dec 02, 2024
pulisher
Nov 30, 2024

1,064,000 Shares in HilleVax, Inc. (NASDAQ:HLVX) Bought by Braidwell LP - MarketBeat

Nov 30, 2024
pulisher
Nov 26, 2024

GSA Capital Partners LLP Acquires New Shares in HilleVax, Inc. (NASDAQ:HLVX) - Defense World

Nov 26, 2024
pulisher
Nov 21, 2024

England's Norovirus Outbreak Peaks Early in 2024 - Precision Vaccinations

Nov 21, 2024
pulisher
Nov 18, 2024

HilleVax, Inc. (NASDAQ:HLVX) Short Interest Update - MarketBeat

Nov 18, 2024
pulisher
Nov 09, 2024

HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% on Disappointing Earnings - Defense World

Nov 09, 2024
pulisher
Nov 09, 2024

HilleVax (NASDAQ:HLVX) Stock Price Down 1.5% Following Weak Earnings - MarketBeat

Nov 09, 2024
pulisher
Nov 08, 2024

HilleVax Reports Q3 Financial Results Amid Strategic Planning - TipRanks

Nov 08, 2024
$60.58
price down icon 3.01%
$69.18
price down icon 5.66%
$17.36
price down icon 8.20%
$31.11
price down icon 2.14%
$88.05
price down icon 4.30%
biotechnology ONC
$238.51
price down icon 9.76%
Capitalizzazione:     |  Volume (24 ore):